Historical record - last NADAC publication: 11/19/2014
Product Information
TAZICEF 1 GRAM VIAL is a generic product labeled by Hospira Inc., priced at $3.7508 per EA under NDC 00409508216. Its NADAC has been published 100 times since Jan 22, 2014.
Strength
1 g/1
Manufacturer
Hospira Inc.NDC
00409508216
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
11/19/2014
Active Ingredients
CEFTAZIDIMEApproval Type
Generic (ANDA)
FDA Application
ANDA062662On Market Since
11/2/2005
Pharmacological Classes
Price Statistics
The NADAC for TAZICEF 1 GRAM VIAL has been published 100 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7508 per EA |
|---|---|
| All-time high | $3.7508 (Dec 16, 2015) |
| All-time low | $3.7257 (Jan 22, 2014) |
| Median price | $3.7508 |
| Average price | $3.7400 |
| Largest weekly change | +0.7% (Nov 19, 2014) |
| Weeks tracked | 100 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CEFTAZIDIME market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TAZICEF 1 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TAZICEF 1 GRAM VIAL, manufactured by Hospira Inc., is $3.7508 per EA (NDC 00409508216), effective Dec 16, 2015.
How has the price of TAZICEF 1 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for TAZICEF 1 GRAM VIAL has held within roughly two percent of its current level. It has been tracked across 100 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for TAZICEF 1 GRAM VIAL?
Since Jan 22, 2014, the NADAC for TAZICEF 1 GRAM VIAL has ranged from a low of $3.7257 (Jan 22, 2014) to a high of $3.7508 (Dec 16, 2015), with a median of $3.7508 per EA.
Are there cheaper alternatives to TAZICEF 1 GRAM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TAZICEF 1 GRAM VIAL, so no direct lower-cost alternative is listed.
Who manufactures TAZICEF 1 GRAM VIAL?
TAZICEF 1 GRAM VIAL (NDC 00409508216) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification